IRIS
DAVI', Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.688
EU - Europa 12.059
AS - Asia 10.412
SA - Sud America 1.682
Continente sconosciuto - Info sul continente non disponibili 1.149
AF - Africa 178
OC - Oceania 6
Totale 43.174
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.052
SG - Singapore 3.895
RU - Federazione Russa 3.256
CN - Cina 2.951
UA - Ucraina 1.879
IE - Irlanda 1.543
TR - Turchia 1.433
BR - Brasile 1.354
IT - Italia 1.115
GB - Regno Unito 1.010
SE - Svezia 994
VN - Vietnam 942
DE - Germania 769
FR - Francia 700
FI - Finlandia 428
IN - India 407
CA - Canada 242
BD - Bangladesh 180
AR - Argentina 128
HK - Hong Kong 112
MX - Messico 99
PL - Polonia 86
EC - Ecuador 67
IQ - Iraq 65
ZA - Sudafrica 61
JP - Giappone 50
CR - Costa Rica 49
ID - Indonesia 48
IL - Israele 47
ES - Italia 46
NL - Olanda 44
CZ - Repubblica Ceca 41
AT - Austria 39
KR - Corea 39
PK - Pakistan 36
CO - Colombia 35
SV - El Salvador 34
HN - Honduras 32
MA - Marocco 31
GT - Guatemala 30
JM - Giamaica 29
TT - Trinidad e Tobago 29
VE - Venezuela 29
EU - Europa 26
PH - Filippine 23
UZ - Uzbekistan 22
NI - Nicaragua 21
CW - ???statistics.table.value.countryCode.CW??? 19
PR - Porto Rico 19
PY - Paraguay 19
SA - Arabia Saudita 19
CL - Cile 18
SC - Seychelles 18
AE - Emirati Arabi Uniti 17
GP - Guadalupe 17
BE - Belgio 16
MY - Malesia 15
IR - Iran 14
LT - Lituania 14
UY - Uruguay 14
AZ - Azerbaigian 13
DZ - Algeria 12
EG - Egitto 11
TN - Tunisia 11
EE - Estonia 10
JO - Giordania 10
KZ - Kazakistan 10
PE - Perù 10
RO - Romania 10
OM - Oman 9
AL - Albania 8
BG - Bulgaria 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
KE - Kenya 8
LB - Libano 8
BO - Bolivia 7
AM - Armenia 6
CH - Svizzera 6
TW - Taiwan 6
BZ - Belize 5
PA - Panama 5
QA - Qatar 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AU - Australia 4
BS - Bahamas 4
DK - Danimarca 4
GR - Grecia 4
KG - Kirghizistan 4
NG - Nigeria 4
NP - Nepal 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BH - Bahrain 3
BM - Bermuda 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
PS - Palestinian Territory 3
PT - Portogallo 3
SI - Slovenia 3
Totale 42.022
Salva come PNG Salva come JPEG
Città #
Singapore 2.956
Jacksonville 2.158
San Jose 1.862
Dublin 1.533
Chandler 1.452
Ashburn 959
Princeton 744
Izmir 733
Dallas 689
Southend 656
Beijing 634
Nanjing 603
Council Bluffs 592
Los Angeles 551
Santa Clara 411
Wilmington 387
Cambridge 340
Ho Chi Minh City 328
Dearborn 299
Altamura 296
Buffalo 244
New York 236
Nanchang 224
Tongling 210
Hanoi 204
Moscow 181
The Dalles 167
Ann Arbor 164
Munich 140
São Paulo 138
Chieti 132
Washington 121
Boardman 113
Hong Kong 106
North Bergen 105
Hebei 103
Shenyang 103
Woodbridge 103
Phoenix 95
Tianjin 91
Kunming 88
Brooklyn 77
Montreal 71
Jiaxing 69
Atlanta 67
Grevenbroich 67
Orem 65
Helsinki 60
Norwalk 58
Warsaw 57
Changsha 54
Redondo Beach 54
Chicago 53
Haiphong 53
Houston 51
Denver 50
Rome 46
Tokyo 45
Milan 43
San José 43
Da Nang 41
Johannesburg 41
Toronto 41
Frankfurt am Main 40
Chennai 39
Hangzhou 38
San Francisco 38
Seoul 37
Augusta 35
Kimball 35
Seattle 35
Mexico City 33
Turku 33
Orange 32
Rio de Janeiro 32
Stockholm 32
Poplar 31
London 30
Baghdad 29
Columbus 29
Pescara 29
Brno 28
Jinan 28
St Louis 28
Belo Horizonte 27
Changchun 27
Lanzhou 27
Boston 26
Brasília 26
Guayaquil 26
Hefei 25
San Mateo 25
San Salvador 25
Shanghai 24
Guatemala City 23
Manchester 23
Mount Pleasant 23
Naples 23
Biên Hòa 22
Mumbai 22
Totale 23.542
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 896
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 886
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 885
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 217
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 206
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 204
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 201
Pentraxin 3 and platelet activation in obese patients after gastric banding 192
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 189
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 183
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 179
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 179
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 179
A comparison of five maintenance therapies for reflux esophagitis 178
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 178
Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis 172
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 172
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 171
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 169
Determinants of platelet activation in hypertensives with microalbuminuria. 167
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 166
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 166
Increased soluble CD40L levels in cystic fibrosis 164
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 164
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 164
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 163
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 162
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 161
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 160
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 159
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 159
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 158
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 156
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 156
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 155
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 155
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 155
Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: Results from the REPOSI registry 155
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 155
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients. 154
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 154
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 154
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 153
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 152
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 152
[The "problem obesity": viewpoint of the internist] 152
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 151
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 150
[The "problem obesity": viewpoint of the internist]. 150
Platelets and Diabetes 150
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 149
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 149
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 148
Leptin increase is associated with markers of the hemostatic system in obese healthy women 147
Aspirin, platelets, and cancer: The point of view of the internist. 147
Insulin resistance as a determinant of platelet activation in obese women. 144
A Complex Interaction between Rickettsia conorii and Dickkopf-1 - Potential Role in Immune Evasion Mechanisms in Endothelial Cells 144
Platelet activation in obesity and metabolic syndrome. 143
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective 143
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 143
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards 143
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 143
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 143
Homocysteine modulates the CD40/CD40L system 142
[Considerations on platelet aggregation inhibition in patients treated with acetylsalicylic acid]. 142
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 142
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 142
Coagulation and infective endocarditis: sooner or later 142
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 142
Association between serum leptin levels and 24-hour blood pressure in obese women. 142
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 141
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 141
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 141
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 140
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 139
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 138
Increased levels of soluble P-selectin in hypercholesterolemic patients 138
Platelets and diabetes mellitus 138
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 137
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 137
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype 137
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 137
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 136
Soluble RAGE in type 2 diabetes: association with oxidative stress. 136
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 136
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 136
Soluble forms of RAGE in internal medicine. 136
Antipsychotic prescription and mortality in hospitalized older persons 136
Diabetes mellitus and thrombosis 135
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 135
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 134
Determinants of platelet activation in hypertensives with microalbuminuria. 134
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 133
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 133
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 132
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 132
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 132
Platelet Activation in Atherothrombosis. 131
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 130
The relationship between clinical events and JAK2V617F mutation status in a cohort of 75 patients with essential thrombocythemia 130
Totale 17.459
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.115 0 0 0 0 104 20 22 121 121 53 216 458
2022/20234.428 432 654 236 425 385 931 302 299 529 45 97 93
2023/20241.949 139 78 136 50 118 633 504 72 18 33 14 154
2024/20255.400 463 1.089 862 67 77 134 82 223 519 207 566 1.111
2025/202613.529 911 482 1.396 1.875 951 642 1.613 732 3.178 999 542 208
2026/20274.007 450 647 593 1.787 530 0 0 0 0 0 0 0
Totale 43.174